Biogen (BIIB)
NASDAQ:BIIB
Holding BIIB?
Track your performance easily

Biogen (BIIB) Financial Statements

4,550 Followers

Biogen Financial Overview

Biogen's market cap is currently ―. The company's EPS TTM is $11.069; its P/E ratio is 15.70; Biogen is scheduled to report earnings on January 30, 2025, and the estimated EPS forecast is $3.44. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue$ 2.47B$ 2.46B$ 2.29B$ 2.39B$ 2.53B
Gross Profit$ 1.83B$ 1.92B$ 1.75B$ 1.77B$ 1.87B
EBIT$ 510.80M$ 760.00M$ 677.90M$ 363.10M$ -77.40M
EBITDA$ 744.50M$ 1.01B$ 869.50M$ 503.20M$ 277.30M
Net Income Common Stockholders$ 388.50M$ 583.60M$ 393.40M$ 249.70M$ 154.70M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Total Assets$ 28.31B$ 26.80B$ 26.57B$ 26.84B$ 28.19B
Total Debt$ 6.65B$ 6.66B$ 6.95B$ 7.34B$ 7.72B
Net Debt$ 6.65B$ 6.66B$ 6.95B$ 7.34B$ 7.72B
Total Liabilities$ 11.95B$ 10.91B$ 11.35B$ 12.05B$ 13.71B
Stockholders Equity$ 16.36B$ 15.89B$ 15.21B$ 14.80B$ 14.48B
Cash Flow-
Free Cash Flow$ 791.20M$ 686.20M$ 432.30M$ -52.70M$ 714.50M
Operating Cash Flow$ 935.60M$ 625.80M$ 553.20M$ 12.50M$ 1.05B
Investing Cash Flow$ -1.18B$ 466.50M$ -66.00M$ -652.30M$ -2.70B
Financing Cash Flow$ -6.60M$ -245.20M$ -439.60M$ -646.10M$ 805.20M
Currency in USD

Biogen Earnings and Revenue History

Biogen Debt to Assets

Biogen Cash Flow

Biogen Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis